Date: December 15, 2023
Time: 12:00-1:00 PM (Pacific Time)
Location: VIRTUAL (Teams-Link below)
Speaker:
Dawn S. Batchuluun, MSW, CCRP
Associate Director, Clinical Trial Services
Global Alzheimer's Platform Foundation
Background:
Dawn Batchuluun currently serves as the Associate Director for Clinical Trial Services at Global Alzheimer's Platform Foundation (GAP). She is a SoCRA Certified Clinical Research Professional (CCRP) with over 20 years of research experience, working at several R1 research institutions across the United States. She has been a research coordinator, leading efforts of single projects, coordinated project activities across multiple sites, and served in several research leadership roles. Prior to joining GAP, Dawn led the Alzheimer’s & Memory Disorders and Parkinson’s & Movement Disorders Research Programs at Barrow Neurological Institute. She has overseen investigator initiated, grant funded, and industry sponsored trials from study conception to closeout. She has a BA in Psychology from the University of Arizona and a Master of Social Work degree from Arizona State University. Dawn comes from the Western Agency of the Navajo Nation in Northern Arizona and now resides in the greater Seattle area in Washington state.
Overview:
1. The Importance of Diversity in Clinical Trials:
• Significance of diversity in clinical trials, emphasizing its impact on the generalizability and effectiveness of research outcomes.
• How diverse participant populations contribute to a more comprehensive understanding of a treatment's safety and efficacy across different demographic groups.
2. Current State of Diversity in Alzheimer's Clinical Trials:
• Overview of the existing demographic composition in Alzheimer's clinical trials.
• Relevant data to illustrate the current state of diversity within the Alzheimer's research space.
3. Global Alzheimer's Platform (GAP) Foundation:
• Mission and objectives of the Global Alzheimer's Platform Foundation.
• GAP's role in facilitating collaboration and innovation in Alzheimer's research on a global scale.
• How GAP serves as a catalyst for transforming the landscape of Alzheimer's clinical trials.
4. GAP's Initiatives to Diversify Clinical Trial Populations:
• Specific initiatives and strategies implemented by GAP to address and improve diversity in Alzheimer's clinical trials.
• How these initiatives have positively impacted trial participation across diverse communities.
• Ongoing efforts and future plans aimed at further enhancing diversity within Alzheimer's research through GAP's interventions.
SOCRA CEUs available: 1 CE for SOCRA Members
{Only SOCRA members receive a certificate of attendance}
COST: FREE (SOCRA members and non-members welcome!)
Join on your computer, mobile app or room device
Click here to join the meeting
Meeting ID: 218 830 886 324
Passcode: S5YWnZ
Download Teams | Join on the web
425899727@t.plcm.vc
Video Conference ID: 116 372 571 33
Alternate VTC instructions
Learn More | Help | Meeting options
SOCRA has sent this email for educational purposes only
SOCRA members and non-members welcome!